Eisai shutters oncology unit, cuts around 80 jobs
19 Jul 2022 //
ENDPTS
H3 Biomedicine Presents Update on Intratumoral E7766 Clinical Program
08 Oct 2021 //
BUSINESSWIRE
H3 Biomedicine Presents Data Update on H3B-6545 for Treatment of Locally
08 Dec 2020 //
BUSINESSWIRE
H3 Biomedicine, Inc. Presents Data Update on H3B-6545 for Treatment of Locally
08 Dec 2020 //
BUSINESSWIRE
Eisai’s H3 Biomedicine appoints new CMO
24 Feb 2020 //
BIOSPECTRUMASIA